Brought to you by:
LimFlow system a ‘cost-effective and high-value alternative’ to traditional therapies
Percutaneous deep vein arterialization (pDVA) with the LimFlow system offers a cost-effective and high-value alternative to traditional therapies or amputation, according to a recent study published in the Journal of Critical Limb Ischemia. Peter Schneider, MD, professor of surgery at…
‘VSITE predicts Qualifying Exam success’
The Vascular Surgery In-Training Examination (VSITE) is “highly predictive” of a Vascular Qualifying Examination pass for examinees following both the integrated vascular surgery (0+5) and vascular fellowship (5+2) training paradigms, Vincent L. Rowe, MD, professor of surgery at the University…
Special session on diversity enters VAM agenda
Over the course of more than a year, diversity, equity and inclusion (DEI) have been brought into sharp focus by a compendium of events inside and outside of medicine. As U.S. society has reckoned with the socioeconomic and cultural consequences…
Just 16% of US centers in VQI offer SVS guideline-compliant open repair for AAA, new study finds
There is a stark downward trend in the number of U.S. centers in the Vascular Quality Initiative (VQI) that meet the Society for Vascular Surgery (SVS) clinical practice guidelines for open repair of abdominal aortic aneurysm (AAA), new research to…
Artio Medical completes enrollment of first-in-human trial investigating Amplifi vein dilation system
Artio Medical announced today it has completed enrollment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated by Adrian Ebner, head of the cardiovascular department at Sanatorio Italiano Hospital in Asunción, Paraguay.…
The year in COVID: VAM to feature 10 talks probing pandemic-related vascular complications
After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of COVID-19 in a special session. The coronavirus session will be from 5 to 6:30 p.m. Wednesday…
Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception
“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons [PCBs] in the peripheral arteries,” findings from a systematic review and meta-analysis of randomized controlled trials (RCTs) published in the European Journal of Vascular and Endovascular…
VESS session: ‘Concerted effort’ made to feature science, discussion from widest possible swath of US
At its very essence, says Vascular & Endovascular Surgery Society (VESS) President Jason T. Lee, MD, vascular surgery is a “social sport.” The specialty is built on the backs of not just the “alpha point guard,” or the surgeon, but…
Study shows increase in risk of renal failure following lytic therapy for acute DVT
A large, single-centre retrospective study has revealed the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower-extremity deep vein thrombosis (DVT) is as high as 22%. This findings add “significant knowledge” to understanding the risks of lytic…
‘COVID-19 sparks diabetic macrophage inflammation’—award-winning paper
When patients with diabetes are infected with coronavirus, specialized macrophage cells—already primed to develop excessive inflammation in this population—are further transformed into a pathologically inflammatory state by a decrease in the enzyme histone methyltransferase, or SETDB2, this year’s SVS Foundation…